Ledger.Open graph →
SEC Form D · filed November 29, 2022

Carmine Therapeutics, Inc

Offering
$13.7M
Sold
$13.7M
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Elan Ezickson · Houston, TXDirectorHarvey Lodish · Boston, MADirectorLin Xiangqian · Cambridge, MADirectorDonald Haut · Cambridge, MAExec · DirectorHarvey Lodish · Boston, MADirectorLin Xiangqian · Cambridge, MADirectorDonald Haut · Cambridge, MAExec · DirectorElan Ezickson · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗